Back

Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry

2 September 2024 (13:25 - 13:35)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk of cancer therapy Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Bi Huang

The First Affiliated Hospital of Chongqing Medical University, Chongqing (China)

5 More presentations in this session

Presentation thumbnail
Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction
Doctor E. Oikonomou (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.
Doctor F. Cribari (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth
Mr B. Van Berlo (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Correlative study to assess the predictive power of the ICOS HF calculator in the prediction of development of HER-2 antagonist induced cardiac dysfunction in a single center in Saudi Arabia in 2023
Doctor M. Al Qaseer (Dammam, SA)
Abstract Slides Video
Presentation thumbnail
Transcatheter mitral edge-to-edge repair in patients with prior cancer diagnosis
Doctor R. Gonzalez-Manzanares (Cordoba, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk of cancer therapy
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 13:25 CET
You may be interested in
thumbnail
Congress Presentation
New onset of atrial fibrillation in patients with cancer: risk-benefit appraisal of anticoagulants
thumbnail
Congress Presentation
Anticoagulants in cancer and atrial fibrillation
thumbnail
Congress Presentation
Individual anticoagulation choices for patients with cancer and atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources